跳至主要内容
临床试验/JPRN-UMIN000034113
JPRN-UMIN000034113已完成未知

Prophylaxis of HBV reactivation by vaccination enforcing post-transplant HBV immunity - PREVENT HBV

ational Center for Global Health and Medicine Genome Medical Science Project0 个研究点目标入组 109 人开始时间: 2018年9月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
109

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) anti-HCV antibody negative (2) anti-HIV antibody negative (3) HBV DNA>=1.3 Log IU/mL (4) anti-HBc antibody negative (5) seroconversion of anti-HBc antibody negative to positive after infusion of blood product (6) previous HBV reactivation (7) previous history of treatment using nucleoside analogue, or plan to prescribe nucleoside analogue for prophylaxis (8) anaphylaxis for previous vaccine (9) conditioning regimen has been started for first HSCT (10) complication of severe infection (11) hemodialysis has been started or planed to be induced (12) uncontrollable diabetics, hypertension or heart failure (13) woman during pregnant or lactation (14) patient who plan to move or plan to be followed by other institute during 2-year after HSCT (15) patient who is not been considered to be eligible to the study by a doctor in charge by miscellaneous reasons

研究者

发起方
ational Center for Global Health and Medicine Genome Medical Science Project

相似试验